Ramipril and Biliary tract disorder - a phase IV clinical study of FDA data

Summary:

Biliary tract disorder is reported as a side effect among people who take Ramipril (ramipril), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Hydrochlorothiazide, and have Carcinoid syndrome.

The phase IV clinical study analyzes which people have Biliary tract disorder when taking Ramipril. It is created by eHealthMe based on reports of 144,209 people who have side effects when taking Ramipril from the FDA, and is updated regularly.

What is Ramipril?

Ramipril has active ingredients of ramipril. It is often used in high blood pressure. eHealthMe is studying from 147,397 Ramipril users. Check the latest studies of Ramipril.

What is Biliary tract disorder?

Biliary tract disorder is found to be associated with 286 drugs and 400 conditions by eHealthMe. Check the latest studies of Biliary tract disorder.

On Jul, 15, 2026

144,209 people reported to have side effects when taking Ramipril.
Among them, 19 people (0.01%) have Biliary tract disorder.

Could Ramipril cause Biliary tract disorder?

Among these 19 people:

How long have people been on Ramipril when they have Biliary tract disorder? *

What is the gender of people who have Biliary tract disorder when taking Ramipril? *

female: 42.11 %
male: 57.89 %

What is the age of people who have Biliary tract disorder when taking Ramipril? *

What are other drugs people take besides Ramipril? *

What are other side effects people have besides Biliary tract disorder? *

Diarrhea: 7 people, 36.84%
Heart Rate Increased: 6 people, 31.58%
Hepatomegaly (abnormal enlargement of the liver): 6 people, 31.58%
Weight Increased: 5 people, 26.32%
Pyogenic Liver Abscess (liver abscess caused by bacteria): 5 people, 26.32%
Abdominal Pain: 5 people, 26.32%
Acute Kidney Failure: 5 people, 26.32%
Bile Duct Stenosis (abnormal narrowing of the common bile duct): 5 people, 26.32%
Cholangitis (infection of the bile duct): 5 people, 26.32%
Hepatic Failure (liver failure): 5 people, 26.32%

What are the existing conditions these people have? *

Carcinoid Syndrome (syndrome includes flushing and diarrhoea, and, less frequently, heart failure and bronchoconstriction): 5 people, 26.32%
Urinary Tract Infection: 3 people, 15.79%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
Renal Cell Carcinoma (a kidney cancer): 2 people, 10.53%
Ill-Defined Disorder: 2 people, 10.53%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 1 person, 5.26%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 5.26%
High Blood Cholesterol: 1 person, 5.26%
Dyslipidaemia (abnormal amount of lipids): 1 person, 5.26%
Chronic Kidney Disease: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Ramipril and have Biliary tract disorder?

- Check whether Biliary tract disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ramipril:

Ramipril (147,397 reports)

Browse all side effects of Ramipril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Biliary tract disorder:

Biliary tract disorder (286 drugs)

Browse all the conditions that are associated with Biliary tract disorder:

Biliary tract disorder (400 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ramipril (the active ingredients of Ramipril) and Ramipril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.